Protein kinase CK2 enhances Mcl‐1 gene expression through the serum response factor‐mediated pathway in the rat hippocampus
- 29 March 2013
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 91 (6) , 808-817
Abstract
The protein kinase CK2 (casein kinase 2) is a ubiquitous serine/threonine protein kinase that suppresses apoptosis. CK2 is composed of catalytic and regulatory subunits, and CK2-dependent phosphorylation is a global mechanism in the inhibition of caspase signaling pathways. The serum response factor (SRF) is an important regulator of cell growth and differentiation. Although CK2 has been shown to phosphorylate SRF in vitro, the biological relevance of this interaction remains largely unclear. We observed increased SRF phosphorylation and increased Mcl-1 gene expression in hippocampal CA1 neurons following transfection with a plasmid expressing the wild-type CK2α (CK2αWT) protein, whereas transfection with a plasmid expressing a catalytically inactive mutant of CK2α (CK2α156A) reduced Mcl-1 gene expression. Cotransfection with a plasmid expressing the inactive SRF99A mutant inhibited the CK2αWT-induced upregulation of Mcl-1 gene expression. The expression of either the CK2α156A or the SRF99A mutant also inhibited the glutamate-induced upregulation of Mcl-1 protein expression in PC12 cells. Our results suggest that CK2-mediated signaling represents a cellular mechanism that may aid in the development of alternative therapeutic strategies to attenuate apoptosis in hippocampal neurons.Keywords
This publication has 34 references indexed in Scilit:
- AMP‐activated protein kinase (AMPK)–induced preconditioning in primary cortical neurons involves activation ofMCL‐1Journal of Neurochemistry, 2012
- Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP‐induced oxidative stressEuropean Journal of Neuroscience, 2012
- Targeting Mcl-1 for the therapy of cancerExpert Opinion on Investigational Drugs, 2011
- Regulation of serum response factor activity and smooth muscle cell apoptosis by chromodomain helicase DNA-binding protein 8American Journal of Physiology-Cell Physiology, 2010
- Casein Kinase II: An attractive target for anti-cancer drug designThe International Journal of Biochemistry & Cell Biology, 2010
- Mcl-1 Is a Key Regulator of Apoptosis during CNS Development and after DNA DamageJournal of Neuroscience, 2008
- Protein kinase CK2 – A key suppressor of apoptosisAdvances in Enzyme Regulation, 2008
- Expression of Mcl-1 in cerebellar granule neurons is regulated by IGF-I in a developmentally specific fashionDevelopmental Brain Research, 2004
- Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neuronsCell Death & Differentiation, 2004
- A Novel Role For Serum Response Factor in Neuronal SurvivalJournal of Neuroscience, 2004